上海莱士血液制品股份有限公司2025年前三季度权益分派实施公告

Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. has announced its profit distribution plan for the first three quarters of 2025, which includes a cash dividend of 0.153 RMB per 10 shares for all shareholders, excluding shares held in the company's repurchase account [2][3][7]. Group 1: Profit Distribution Plan - The profit distribution plan was approved at the third extraordinary general meeting of shareholders held on December 15, 2025 [3][5]. - The cash dividend will be distributed based on the total share capital excluding the 69,081,952 shares held in the repurchase account, resulting in a total of 6,568,902,885 shares eligible for the dividend [2][7]. - The total cash dividend amount is calculated to be 100,504,214.14 RMB, with an adjusted per-share dividend of 0.0151407 RMB [2][11]. Group 2: Dividend Payment Details - The record date for the dividend distribution is set for February 9, 2026, and the ex-dividend date is February 10, 2026 [7][8]. - Cash dividends will be directly credited to shareholders' accounts through their securities companies on the ex-dividend date [9]. - The company will not issue bonus shares or convert reserves into share capital as part of this distribution [4][5]. Group 3: Tax Implications - Different tax rates will apply to various categories of shareholders, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [7]. - The tax implications for individual shareholders will depend on their holding period, with specific amounts to be paid based on the duration of their shareholding [7].